Display search results for ** instead (64 products)

Showing 1-10 of 64

This edition of the Genetic Technology TOE provides insights across new gene therapy technologies enabling enhanced management of neurological disorders. The service encompasses the impact and opportunity of gene therapy technologies in the neuroscience industry, while providing an overview of IP and R&D trends in this space. Additionally, this TOE...

USD 250.00

USD 187.50 save 25 %

The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across chemotherapy personalization, cell transplantation, multi-drug resistance studies, and adult stem cell regeneration. The corresponding clinical trials scenario related to monoclonal antibody drugs for autoimmune diseases is also depicted. The Health & Wellness cluste...

USD 250.00

USD 187.50 save 25 %

This Genetic Technology TOE depicts life sciences trends across digital innovations, including, digital genomics and artificial intelligence (AI)-driven medicine. Clinical trials for Propeller Health Platform is also depicted. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an empha...

USD 250.00

USD 187.50 save 25 %

This edition of the Inside R&D TOE depicts trends in a series of developments associated with biodegradable pressure sensors for healthcare applications, cancer diagnosis, and implantable devices. It also focuses on innovations in drug discovery and humidity control. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are...

USD 250.00

USD 187.50 save 25 %

The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across biomarker assays and stem cell therapies. A blood test for traumatic brain injury, use of umbilical cord mesenchymal stem cells and adipose-derived mesenchymal stem cells for treatment of liver cirrhosis, and using mesenchymal stem cells for treatment of ulcerative c...

USD 250.00

USD 187.50 save 25 %

The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across diabetes care, CAR-T cell therapy, pedriatic and genetic disease treatment. Novel solutions for pancreatic islet transplants, CAR-T cell therapy, enzyme replacement therapy, and autism correlations are profiled. Clinical trials scenario for Alzheimer's disease is also...

USD 250.00

USD 187.50 save 25 %

The Genetic Technology TechVision Opportunity Engine (TOE) depicts the current landscape and the new life sciences trends across precision medicine. Precision medicine strategies targeting mRNA splicing, novel therapies for inherited disorders, microbiome-based therapies for inflammatory diseases, and gene editing technologies fueling personalized ...

USD 250.00

USD 187.50 save 25 %

This Genetic Technology TOE depicts life sciences trends across cystic fibrosis. First-in class mRNA therapeutics with targeted delivery, novel cell types, lentiviral gene therapy, and RNA vaccines, among other therapies are profiled. Clinical trials of RNA vaccines for the cancer treatment are also depicted. The Genetic Technology TechVision Oppo...

USD 250.00

USD 187.50 save 25 %

This Genetic Technology TOE depicts new life sciences trends across digital targeted therapeutic platforms. Human genetics, antibody therapies, digital oncology platforms, among others, are profiled. The clinical trials scenario for FoundationOne Platform is along depicted. The Genetic Technology TechVision Opportunity Engine (TOE) presents the la...

USD 250.00

USD 187.50 save 25 %

The Genetic Technology TechVision Opportunity Engine (TOE) outlines the impact of artificial intelligence (AI) on the global drug discovery and development landscape. Berg Health’s precision medicine platforms and a clinical overview of the company’s pipeline have been profiled in the TOE. Furthermore, IP trends, research aspects, and AI-medici...

USD 250.00

USD 187.50 save 25 %

Showing 1-10 of 64